Suven Life Sciences is trading -6.56% lower at Rs 116.00 as compared to its last closing price. Suven Life Sciences has been trading in the price range of 125.75 & 114.65. Suven Life Sciences has given -2.78% in this year & -4.89% in the last 5 days. The company posted a net profit of -49.64 Crores in its last quarter.Listed peers of Suven Life Sciences include Solara Active Pharma Sciences (-2.79%), Alembic (-4.14%), Suven Life Sciences (-6.56%).The Mutual Fund holding in Suven Life Sciences was at 1.05% in 31 Dec 2024. The MF holding has decreased from the last quarter. The FII holding in Suven Life Sciences was at 0.34% in 31 Dec 2024. The FII holding has increased from the last quarter.
Updated on Feb 14, 2025, 11:31 AM UTC
|
|
|
|
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
---|---|---|---|---|---|---|---|---|
Solara Active Pharma Sciences | Bearish | 488.05 | -2.79 | 2,655.60 | - | 2.23 | - | 12.58 |
Alembic | Bearish | 99.45 | -4.14 | 2,553.00 | 10.80 | 1.33 | 2.13 | 0.34 |
Suven Life Sciences | Bearish | 116.00 | -6.56 | 2,529.27 | - | 10.65 | - | - |
Gujarat Themis Biosyn | Bearish | 249.15 | -4.36 | 2,714.87 | 48.57 | 14.27 | 0.25 | 0.61 |
Indoco Remedies | Bearish | 245.45 | -1.98 | 2,267.89 | 28.57 | 2.33 | 0.54 | 32.81 |
Meeting Date | Purpose |
---|---|
2025-01-24 | Quarterly Results |
2024-10-29 | Quarterly Results |
2024-08-05 | Quarterly Results |
2024-05-06 | Audited Results |
2024-01-30 | Quarterly Results |
Suven Life Sciences is trading at 116.00 as on Fri Feb 14 2025 09:59:57. This is -6.56% lower as compared to its previous closing price of 124.15.
The market capitalization of Suven Life Sciences is 2529.27 Cr as on Fri Feb 14 2025 09:59:57.
The 52 wk high for Suven Life Sciences is 169.00 whereas the 52 wk low is 83.27
Suven Life Sciences can be analyzed on the following key metrics -
Suven Life Sciences reported a net profit of -105.08 Cr in 2024.
The Mutual Fund Shareholding was 1.05% at the end of 31 Dec 2024.